Publication | Open Access
A phase 2 trial investigating the efficacy and safety of the mPGES-1 inhibitor vipoglanstat in systemic sclerosis-related Raynaud's
10
Citations
18
References
2024
Year
ClinicalTrials.gov, https://www.clinicaltrials.gov, NCT0474420.
| Year | Citations | |
|---|---|---|
Page 1
Page 1